PMID: 241785Oct 1, 1975Paper

Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components

The Journal of Pharmacy and Pharmacology
M H Bickel


The binding of model drugs to human blood and individual blood components has been determined by equilibrium dialysis and expressed in terms of classes of binding sites, association constants and binding capacities. Chlorpromazine and imipramine are bound to three major components: membranes of red cells, albumin, and lipoproteins. The affinity and capacity of lipoprotein binding is at least as high as that of albumin and is equally distributed on HDL, LDL, VLDL, and on the chylomicrons. White blood cells and platelets are of minor importance in terms of binding capacity. No binding was detected with gamma-globulins or alpha- or beta-globulins other than lipoproteins. In contrast, salicylic acid was not bound to red cells or lipoproteins.


Feb 1, 1974·The Journal of Pharmacy and Pharmacology·G Powis
Aug 1, 1974·The Journal of Pharmacy and Pharmacology·D Sharples
Jan 1, 1971·Naunyn-Schmiedebergs Archiv Für Pharmakologie·R MinderM H Bickel
Mar 28, 1974·Biochimica Et Biophysica Acta·S GhoshJ S Schweppe
Feb 1, 1966·The Journal of Pharmacy and Pharmacology·L Ahtee, M K Paasonen
Mar 1, 1969·The Journal of Pharmacy and Pharmacology·M H Bickel, H J Weder
Jan 1, 1971·The Journal of Pharmacy and Pharmacology·J N McArthurM J Smith
Aug 15, 1974·Experientia·J KrieglsteinD H Niemeyer
Nov 26, 1973·Annals of the New York Academy of Sciences·P G DaytonJ M Perel
Nov 26, 1973·Annals of the New York Academy of Sciences·J R Gillette
Jan 1, 1973·Advances in Clinical Chemistry·V MarksE M Baylis
Nov 1, 1972·Chemical & Pharmaceutical Bulletin·N Nambu, T Nagai
Mar 1, 1974·Chemico-biological Interactions·M H Bickel, J W Steele
Jun 15, 1974·Biochemical Pharmacology·J F ZaroslinskiY T Oester
Jun 1, 1968·Journal of Pharmaceutical Sciences·M C Meyer, D E Guttman
Jan 1, 1961·The American Journal of Clinical Nutrition·F T LindgrenR D Wills

❮ Previous
Next ❯


Jan 1, 1996·Journal of Basic Microbiology·K Balakrishnan, A Pandey
Nov 15, 1977·Psychopharmacology·L F GramO Krautwald
Jan 1, 1980·Psychopharmacology·D CostaT Ciurezu
Jul 31, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·M Brinkschulte, U Breyer-Pfaff
Jan 1, 1984·European Journal of Clinical Pharmacology·L A Asali, K F Brown
Jan 1, 1982·European Journal of Clinical Pharmacology·L HolmbergL O Boréus
Jan 1, 1985·European Journal of Clinical Pharmacology·C B Kristensen
Jan 1, 1980·Lung·Z H SiddikT E Gram
Jan 1, 1980·European Journal of Drug Metabolism and Pharmacokinetics·C Plessas, A Benakis
Jan 1, 1986·European Journal of Drug Metabolism and Pharmacokinetics·K KawaharaY Hashimoto
Mar 1, 1977·Chemico-biological Interactions·C D Francesco, M H Bickel
Oct 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·T C Kwong
Aug 1, 1976·European Journal of Pharmacology·M SalazarP N Patil
Sep 30, 1979·Toxicology and Applied Pharmacology·Z H SiddikT E Gram
Aug 1, 1988·Journal of Biochemical and Biophysical Methods·M Yamamoto, H Aki
Apr 1, 1986·Psychiatry Research·A I BarkaiT B Cooper
Jun 1, 1990·Psychiatry Research·R C Arora, H Y Meltzer
Apr 16, 2004·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Dilson SilvaSônia R W Louro
Jun 6, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·S M AltamentovaY I Miller
Sep 1, 1990·The Journal of Pharmacy and Pharmacology·H Aki, M Yamamoto
Nov 3, 2005·Environmental Health Perspectives·Ricky T WoofterJohn S Ramsdell
Dec 1, 1977·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R Stegmann, M H Bickel
Jan 1, 1983·Drug Metabolism Reviews·G R Wilkinson
Jan 1, 1983·Drug Metabolism Reviews·H Kurz, B Fichtl
Aug 1, 1976·Journal of Pharmaceutical Sciences·F W Goodhart, M L Eichman
Apr 1, 1980·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A R Beaubien, A P Pakuts
Apr 21, 1998·Journal of Pharmaceutical Sciences·K M Wasan, S M Cassidy
May 1, 1987·British Journal of Clinical Pharmacology·T W GuentertM Rowland
Jul 1, 1982·British Journal of Clinical Pharmacology·P BaumannJ Schöpf
Apr 1, 1984·British Journal of Clinical Pharmacology·C La RosaL E Mather
Jul 21, 2004·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D SilvaS R W Louro

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.